Answer
Zonegran (zonisamide) capsules are licensed for partial seizures, with or without secondary generalisation, as monotherapy in adults with newly diagnosed epilepsy and as adjunctive therapy in adults, adolescents and children aged 6 years and above.
Sources for this answer
- Zonegran 25 mg Hard CapsulesADVANZ Pharma · emc · SmPC §4.1 Therapeutic Indications · Version 34Document updated
Sources checked